Tanhente, Aires J.
HRN: 18-13-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
CEFTRIAXONE 1G (VIAL)
09/02/2023
09/09/2023
IV
650
Q12
Pcap-C
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes